Ubs Ag London Branch Autocallable Contingent Interest Barrier N (ABMATXX)

OBAI! rebounding

watching paint dry progresses faster than this company does anything.

I meant the Grotto itself.

Morning trades: Sold 4 puts in SPCX, 10 in NVDA, 2 in MCK, 3 in CIEN. Rt trade in JPM.
Added: FCFS, CRDO, CIEN, VSXY.
Sold FAF and rt in VSEC.

Don't forget this was 6 bucks in May of this year.The share volume is 6 times the OS.You know that they are issuing hundreds of millions more shares.That is almost always followed by a RS.They steal your shares and line their pockets before moving on.Sound familiar,well it should,this is your classi

Everybody is also bringing up these contracts obviously some here will know a lot more than me regarding that side but to my knowledge there is zero publically released information that contracts are imminent or exist at all. I went through all my notes 3 times other than NNC I don't believe a singl

U.S. 18 Series launch momentum — $COSM Cosmos Health said four launched 18 Series products are targeting over $22.7M in annualized U.S. revenue and about $17.0M in implied gross profit at roughly 75% gross margin.

https://www.globenewswire.com/news-release/2026/06/15/3311839/0/en/Cosm

$CBDW 1606 Corp is pushing into AI infrastructure with a Texas power-backed data-center project, a 132-acre site, 50,000 sq. ft. facility, and Sim Agro energy-operations acquisition. Financing and closing updates could be major catalysts ahead.

https://cbdw.ai/

the run is over here peeps,this one is headed back to trips,those with eyes can see this slow drifting down,its an otc stock peeps dont fall for the trap and fall in love,trade um and move on to the next one,not bashing the stock at all and nothing personal i made a small profit here so that is tha

Check Point and Illumio Expand Partnership to Deliver Protection and Resilience Against Frontier AI-Powered AttacksJune 16, 2026 11:28 AM
PR Newswire (US) As frontier AI models compress the entire attack lifecycle, Check Point and Illumio

Fake longs, the few that are pumping the loudest, are selling the most....

VTGN 0.60 -Phase3 data within 14days , has low marketcap of 24million trading below its Cash of 45 million dollar .

https://finance.yahoo.com/sectors/healthcare/articles/vistagen-reports-fiscal-2026-financial-203000481.html

"Completed randomized portion of PALISADE4 Pha

BIG Buys printing. This is getting very interesting

Yes, sir. :)

Its not BS though. The sooner you realize that the better for you.

Another rinse and repeat day….gettin mighty tired of them

I wondered where this loyal investor came from.

In checking I realized he/she was put on my ignore list some time ago.

Concluded at the time that this was a fry cook at Mickey D’s who had hacked into their order/entry system to post on the Internet. Mom and Dad won’t l

For Buckey:

https://oceanofpdf.com/authors/stephen-j-harper/pdf-epub-a-great-game-the-forgotten-leafs-and-the-rise-of-professional-hockey-download-72160980026/

JPM on the move again 329 PLUA 10$ and my contention is that they want their STOCK AS HIGH AS THYE CAN get it before having to issue shares to US FOR WHAT THEY STOLE
Lets see if I am correct as they are just a few $ away from their all-time high of 337

Yes they were. :)

VRDN $16 pdufa date set June 30th pending fda news as well -> The FDA Prescription Drug User Fee Act (PDUFA) target action date for Viridian Therapeutics' (NASDAQ: VRDN) Biologics License Application (BLA) for veligrotug (for the treatment of thyroid eye disease) is June 30, 2026

LOL, if KW had come out with a PR promoting the Electrome deal before she had the deposit/payment for the initial order you would have roasted her and said it was another Synergy. She is following the, 'Once burnt, twice shy' protocol, holding off on the promotion of the deal until the cash is in ha

VTGN 0.60-Phase3 data within 14days , has low marketcap of 24million trading below its Cash of 45 million dollar .

https://finance.yahoo.com/sectors/healthcare/articles/vistagen-reports-fiscal-2026-financial-203000481.html

"Completed randomized portion of PALISADE4 Phas